DIPG-42. THE COMBINATION OF THE CDK4/6 INHIBITOR PALBOCICLIB WITH THE RAPALOGUE TEMSIROLIMUS INHIBITS DIPG CELL PROLIFERATION VIA SYNERGISTIC ATTENUATION OF CELL CYCLE REGULATORS (2017)
Attributed to:
Malignant Glioma immunotherapy by histone deacetylase inhibition administered by convection enhanced delivery.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/nox083.057
Publication URI: http://dx.doi.org/10.1093/neuonc/nox083.057
Type: Journal Article/Review
Parent Publication: Neuro-Oncology
Issue: suppl_4